One out of eight women develop breast cancer in the United States during their lifetime. In Europe, the ratio is one in ten women. Although the incidence rate of breast cancer is not declining, millions of lives are being saved by early detection and improved treatments. When breast cancer is discovered in its earliest stage (confined to the breast), the 5-year survival rate is as high as 76%; if it is diagnosed at a distant stage (spread to one or more distant organs), the 5-year survival rate is approximately 21%.

Breast cancer is the most common cancer in women worldwide. It is estimated that every thirteen minutes a woman dies of breast cancer. These numbers in the next generation will drop significantly with the help of (BDS) and its painless, accurate and quick diagnostic technology offered to women today. To understand what one is up against first take a look at what it really is, A better understanding of what cancer is will help reiterate the importance of the (BDS) technology.

Cancer occurs when cells no longer reproduce normally. Normal cells reproduce only when instructed to do so by other cells in their vicinity. This relationship ensures that each tissue maintains a size and architecture appropriate to the body's needs. Cancer cells do not respond to the usual controls of proliferation stimulated by surrounding normal cells; they follow their own internal agenda for reproduction. (In essence these cancer cells do not follow normal patterns of cell growth, thus following a pattern all their own) Cancer cells also have the ability to migrate from their site of origin, invade nearby tissues and form masses, called malignant tumors, at distant sites in the body. These malignant tumors become more aggressive over time, disrupting the regular functions of tissues and organs, ultimately resulting in death. Carcinomas, the most common forms of cancer, originate in the epithelial cells, which line the body cavities. Breast cancer is an epithelial cancer, making it so common in women.